251 related articles for article (PubMed ID: 31502527)
1. An integrated computational approach to identify GC minor groove binders using various molecular docking scoring functions, dynamics simulations and binding free energy calculations.
Soni MN; Kumar SP; S R KJ; Rawal RM; Pandya HA
J Biomol Struct Dyn; 2020 Aug; 38(13):3838-3855. PubMed ID: 31502527
[TBL] [Abstract][Full Text] [Related]
2. Ligand-based pharmacophore modelling and screening of DNA minor groove binders targeting Staphylococcus aureus.
Vijayalakshmi P; Selvaraj C; Shafreen RM; Singh SK; Pandian SK; Daisy P
J Mol Recognit; 2014 Jul; 27(7):429-37. PubMed ID: 24895275
[TBL] [Abstract][Full Text] [Related]
3. Comparison of computational methods to model DNA minor groove binders.
Srivastava HK; Chourasia M; Kumar D; Sastry GN
J Chem Inf Model; 2011 Mar; 51(3):558-71. PubMed ID: 21375336
[TBL] [Abstract][Full Text] [Related]
4. Structural Investigation of Vinca Domain Tubulin Binders by Pharmacophore, Atom based QSAR, Docking and Molecular Dynamics Simulations.
Athar M; Lone MY; Khedkar VM; Radadiya A; Shah A; Jha PC
Comb Chem High Throughput Screen; 2017; 20(8):682-695. PubMed ID: 28486912
[TBL] [Abstract][Full Text] [Related]
5. Pharmacophore modeling, multiple docking, and molecular dynamics studies on Wee1 kinase inhibitors.
Hu Y; Zhou L; Zhu X; Dai D; Bao Y; Qiu Y
J Biomol Struct Dyn; 2019 Jul; 37(10):2703-2715. PubMed ID: 30052133
[TBL] [Abstract][Full Text] [Related]
6.
Issar U; Arora R; Kakkar R
J Biomol Struct Dyn; 2024 Jun; 42(9):4537-4552. PubMed ID: 37301606
[TBL] [Abstract][Full Text] [Related]
7. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine.
Chaudhari HK; Pahelkar A
Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898
[TBL] [Abstract][Full Text] [Related]
8. The mutagenic properties of DNA minor-groove binding ligands.
Turner PR; Denny WA
Mutat Res; 1996 Aug; 355(1-2):141-69. PubMed ID: 8781582
[TBL] [Abstract][Full Text] [Related]
9. Dynamic hydrogen bonding and DNA flexibility in minor groove binders: molecular dynamics simulation of the polyamide f-ImPyIm bound to the Mlu1 (MCB) sequence 5'-ACGCGT-3' in 2:1 motif.
Bruce CD; Ferrara MM; Manka JL; Davis ZS; Register J
J Mol Recognit; 2015 May; 28(5):325-37. PubMed ID: 25711379
[TBL] [Abstract][Full Text] [Related]
10. Large scale free energy calculations for blind predictions of protein-ligand binding: the D3R Grand Challenge 2015.
Deng N; Flynn WF; Xia J; Vijayan RS; Zhang B; He P; Mentes A; Gallicchio E; Levy RM
J Comput Aided Mol Des; 2016 Sep; 30(9):743-751. PubMed ID: 27562018
[TBL] [Abstract][Full Text] [Related]
11. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
[TBL] [Abstract][Full Text] [Related]
12. Targeting protein tyrosine phosphatase to unravel possible inhibitors for Streptococcus pneumoniae using molecular docking, molecular dynamics simulations coupled with free energy calculations.
Zaman Z; Khan S; Nouroz F; Farooq U; Urooj A
Life Sci; 2021 Jan; 264():118621. PubMed ID: 33164832
[TBL] [Abstract][Full Text] [Related]
13. In silico trials to design potent inhibitors against matrilysin (MMP-7).
Katari SK; Pasala C; Nalamolu RM; Bitla AR; Umamaheswari A
J Biomol Struct Dyn; 2022; 40(22):11851-11862. PubMed ID: 34405760
[TBL] [Abstract][Full Text] [Related]
14. Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches.
Jana S; Singh SK
J Biomol Struct Dyn; 2019 Mar; 37(4):944-965. PubMed ID: 29475408
[TBL] [Abstract][Full Text] [Related]
15. Binding to the DNA Minor Groove by Heterocyclic Dications: from AT Specific to GC Recognition Compounds.
Paul A; Nanjunda R; Wilson WD
Curr Protoc; 2023 Apr; 3(4):e729. PubMed ID: 37071034
[TBL] [Abstract][Full Text] [Related]
16. Targeting the NF-κB/IκBα complex via fragment-based E-Pharmacophore virtual screening and binary QSAR models.
Kanan T; Kanan D; Erol I; Yazdi S; Stein M; Durdagi S
J Mol Graph Model; 2019 Jan; 86():264-277. PubMed ID: 30415122
[TBL] [Abstract][Full Text] [Related]
17. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
18.
Tran TT; Tran QH; Duong CQ; Nguyen QT; Tran VT; Le MT; Tran VH; Thai KM
J Biomol Struct Dyn; 2023; 41(22):13154-13167. PubMed ID: 36709441
[TBL] [Abstract][Full Text] [Related]
19. Exploration of interaction behavior between spiro[indene-2,2'-[1,3,5]oxathiazine]-1,3-diones and DNA with the help of DFT, molecular docking, and MD simulations.
Salehpour M; Azizian J
J Biomol Struct Dyn; 2022; 40(19):9194-9213. PubMed ID: 33998964
[TBL] [Abstract][Full Text] [Related]
20. Discovery of potential HER2 inhibitors from
Balogun TA; Iqbal MN; Saibu OA; Akintubosun MO; Lateef OM; Nneka UC; Abdullateef OT; Omoboyowa DA
J Biomol Struct Dyn; 2022; 40(23):12772-12784. PubMed ID: 34514973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
